You just read:

Statement from Novartis Pharmaceuticals Canada Inc. regarding availability of Bexsero®, a meningitis B (MenB) vaccine, in Quebec

News provided by

Novartis Pharmaceuticals Canada Inc.

Feb 25, 2014, 18:10 ET